companydata.dkcompanydata.dk

TJ Biotech Holding ApS: Financial statements 2022

CVR: 41953616

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 53,543 and a net result of DKK -215,772 compared with DKK 412,666 the year before. That is a decrease of 96.9% compared with the year before. Equity in the 2022 report amounted to DKK 23,268,358. The solvency ratio was 98.1%.

Gross Profit
DKK 53,543
Profit/Loss
DKK -215,772
Equity
DKK 23,268,358
Total Assets
DKK 23,731,101
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-54K-216K23.3M0
2021-1.7M413K23.5M1
2020-1.4M90K23.1M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on TJ Biotech Holding ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

TJ Biotech Holding ApS: The 2021 annual report is outJul 6, 2022

TJ Biotech Holding ApS has published its annual report for 2021. Gross profit came to DKK 1,749,111, and the net result was DKK 412,666.

About TJ Biotech Holding ApS

TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.

Source: annual report 2025, Danish Business Authority

Other financial years